The Moroccan Society for Primary Immunodeficiencies (MSPID) organised its 10th Congress, dedicated to “Genetic predisposition to infection, Inflammation and Allergy” along with the 1st Maghreb Immunoglobulin Expert meeting. The meetings took place in Casablanca, on October 5-7 and gave medical experts the opportunity to learn from each other about management of primary immunodeficiencies in the region.
By Martine Pergent, IPOPI vice-president

The programme of both meetings was very interesting with topics that included new developments in PIDs, new developments in Common Variable Immunodeficiency (CVID), respiratory diseases in adults, genetic testing, clinical management and vaccination.  The introduction of subcutaneous administration of immunoglobulins (SCIG) in Morocco was done recently and several Moroccan patients and parent were invited to give their testimonies on their experience with SCIG. They feel very proud to be able to manage themselves.

Speakers and participants brought different experiences from Morocco, Tunisia, Algeria, France, Senegal, Saudi Arabia and Germany  and shared their views.

I was invited, as IPOPI vice-president and as a representative for Africa, to give a talk on the Potential for Management for PIDs in Africa from a Patient Perspective after an IPOPI article with the same name was published in the Health Moroccan magazine and replicated in the October ASID letter.

This was a great meeting, with important contents, sharing, even decision, including celebration and friendship, all for the sake of PID patients in the region.